Sign In
Buy GDRX
$2.57
-0.0900 (-3.38%)
At Close: Jun 22, 2026
GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer
04:05pm, Monday, 16'th Dec 2024
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced that Wendy Barnes has been appointed as President an
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
09:00am, Thursday, 05'th Dec 2024
Prescription fills for blockbuster weight loss medications in the U.S. more than doubled in 2024, even with limited insurance coverage and high out-of-pocket costs for the treatments. That's according
GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged
09:00am, Thursday, 05'th Dec 2024
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications Tracker that provides an inside look a
GoodRx initiated with a Neutral at Mizuho
04:32pm, Tuesday, 03'rd Dec 2024
Mizuho analyst Steven Valiquette initiated coverage of GoodRx with a Neutral rating and $5 price target. Following an "upbeat analyst meeting" in May that included 6%-12% revenue compound annual growt
GoodRx Helps Announces Recipients of 2024 Students for Healthcare Equity Scholarship
09:00am, Monday, 18'th Nov 2024
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Helps, a 501(c)(3) nonprofit organization seeking to address health inequities across the country, has selected its 2024 Students for Healthcare Equity Sc
Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm
12:38pm, Wednesday, 13'th Nov 2024
NEW YORK , Nov. 13, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of GoodRx Holdings, Inc. (NASDAQ: GDRX) breached
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc. (NASDAQ: G
Why GoodRx Holdings Stock Was Sinking This Week
07:15am, Friday, 08'th Nov 2024
The company is growing key fundamentals. However, the improvements weren't enough to impress the market.
GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript
02:14pm, Thursday, 07'th Nov 2024
GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript
GoodRx (GDRX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10:35am, Thursday, 07'th Nov 2024
While the top- and bottom-line numbers for GoodRx (GDRX) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compar
GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates
08:26am, Thursday, 07'th Nov 2024
GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.06 per share a year ago.
GoodRx Reports Third Quarter 2024 Results
06:05am, Thursday, 07'th Nov 2024
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released
GoodRx (GDRX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:20am, Wednesday, 06'th Nov 2024
Beyond analysts' top -and-bottom-line estimates for GoodRx (GDRX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
GoodRx and CVS Sued for Suppressing Pharmacy Reimbursement
03:44pm, Tuesday, 05'th Nov 2024
Smaller pharmacies are accusing GoodRx and CVS of colluding to suppress generic prescription drug reimbursements. As Reuters reported Tuesday (Nov. 5), drug coupon aggregator GoodRx and a pair o
GoodRx to Participate in Upcoming Investor Conferences
04:05pm, Monday, 04'th Nov 2024
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives
